Signal EN / Medical Devices
BrainsWay Ltd. 2026-08-13
BrainsWay Q2 2026: Revenue Growth, Operating Leverage, and the Guidance Test
BrainsWay's SEC-filed Q2 release shows 35% revenue growth, higher operating income, positive operating cash flow, and raised 2026 guidance.
signal-nasdaq-bway-20260813
signal:BWAY:2026-08-12